Ascendis Pharma A/S ASND
253.45 USD -4.48 (-1.74%)
At closeNov 5, 2026, 4:39 PM EST
253.45 0.00 0.00%
After hours · Nov 5, 4:39 PM ET
251.96 Day range 257.93
188.07 52-week range 282.15
- YTD
- +18.86%
- 1 year
- +28.17%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 720.13M | 363.64M | 266.72M | 51.17M | 7.78M | |
| 625.22M | 319.38M | 222.32M | 39.04M | 4.25M | |
| -136.27M | -278.76M | -455.54M | -561.81M | -451.79M | |
| -228.03M | -378.08M | -481.45M | -583.19M | -383.58M | |
| -3.76 | -6.53 | -8.55 | -10.40 | -7.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 616.04M | 559.54M | 392.16M | 444.77M | 446.27M | |
| 1.30B | 1.18B | 825.59M | 1.09B | 1.08B | |
| 1.47B | 1.29B | 971.28M | 826.39M | 201.29M | |
| 871.79M | 1.01B | 787.56M | 666.33M | 104.96M | |
| -162.82M | -105.71M | -145.70M | 263.35M | 883.63M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 53.90M | -306.20M | -467.36M | -495.70M | -417.65M | |
| -8.48M | 6.88M | 286.47M | 61.73M | -110.58M | |
| 36.33M | 443.93M | 134.29M | 396.77M | 351.39M | |
| -8.48M | -477.00K | -2.39M | -4.95M | -24.23M | |
| 81.74M | 144.61M | -46.59M | -37.19M | -176.84M |